Trial Profile
The Effect of Food on the Pharmacokinetics of the Proposed Commercial Formulation of Abemaciclib in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Abemaciclib (Primary)
- Indications Brain cancer; Breast cancer; Cancer; Glioblastoma; Liposarcoma; Mantle-cell lymphoma; Non-small cell lung cancer; Pancreatic cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 19 Oct 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 06 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
- 29 Jun 2015 New trial record